Armata Pharmaceuticals, Inc. — Director's Dealing 2015

Sep 10, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AmpliPhi Biosciences Corp (APHB)
CIK: 0000921114
Period of Report: 2015-09-08

Reporting Person: Johnson Wendy S. (Director, See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-08	Stock Option (right to buy)	$7.46	A	49965	Acquired	2025-09-08	Common Stock (49965)	Direct

Footnotes

F1: One-half of the shares underlying this option will vest and become exercisable upon AmpliPhi Bioscience Corporation's (the "Company") satisfaction of certain business goals. One-half of the shares underlying this option will vest on an equal monthly basis over the 12 months following July 1, 2015, subject to the Consulting Agreement, dated September 3, 2015, by and between the Company and Wendy S. Johnson, remaining in effect as of the applicable vesting date.